RecruitingPhase 4NCT06807866

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

Use of Duloxetine for Perioperative Pain Control After Total Hip Arthroplasty: Randomized Controlled Clinical Trial (RCT)

Sponsor

University of Miami

Enrollment

64 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

THA

Summary

The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Duloxetine and Placebo for people with tha. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDuloxetine

Participants will come in person and receive a one time 60 mg dose by mouth.

OTHERPlacebo

Participants will come in person and receive a one time 60 mg placebo pill dose by mouth.

Locations(1)

University of Miami

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06807866

Related Trials

Binaural Beats for Postoperative Pain and Anxiety Reduction

NCT074374691 location

Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)

NCT068310451 location